Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective targeting of skeletal muscle resident fibro-adipogenic progenitors via recombinant adeno-associated viral delivery.

Scientific reports·2026
Same author

Resident mesenchymal progenitor cells require autocrine IGF-I in homeostatic and regenerating skeletal muscle.

Stem cell reports·2026
Same author

Pilot analysis of protein profile alterations in plasma and aortic tissue of spontaneously hypertensive rats.

Acta biochimica Polonica·2026
Same author

The Role of Next-Generation Sequencing in Cardiovascular Disease: A New Era of Precision Cardiology.

Life (Basel, Switzerland)·2026
Same author

Open Pilonidal Excision as a Translational Human Model for Wound Healing and Skin Regeneration Research.

Biomedicines·2026
Same author

Reduced skeletal muscle perfusion accompanies skeletal muscle atrophy after severe spinal cord injury.

Journal of applied physiology (Bethesda, Md. : 1985)·2026

Related Experiment Video

Updated: Apr 27, 2026

Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model
08:03

Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model

Published on: June 11, 2017

13.3K

Optimizing IGF-I for skeletal muscle therapeutics.

Anastassios Philippou1, Elisabeth R Barton2

  • 1Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|July 9, 2014
PubMed
Summary

Insulin-like Growth Factor-I (IGF-I) promotes muscle growth and repair. Optimizing IGF-I pathways offers potential for skeletal muscle therapeutics by enhancing bioavailability and potency.

Keywords:
AnabolismHypertrophyIsoformsPost-translational processingSatellite cells

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.8K
Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice
07:48

Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice

Published on: September 16, 2019

9.6K

Related Experiment Videos

Last Updated: Apr 27, 2026

Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model
08:03

Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model

Published on: June 11, 2017

13.3K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.8K
Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice
07:48

Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice

Published on: September 16, 2019

9.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Muscle Physiology

Background:

  • Insulin-like Growth Factor-I (IGF-I) is crucial for cell growth and survival.
  • IGF-I signaling involves complex interactions of isoforms, intracellular components, and receptors.
  • IGF-I is recognized for its role in muscle growth, repair, mass, and strength.

Purpose of the Study:

  • To review the complex IGF-I system in muscle.
  • To explore optimizing IGF-I pathways for anabolic processes in muscle.
  • To discuss advances in IGF-I bioavailability, potency, and tissue response for skeletal muscle therapeutics.

Main Methods:

  • Literature review of IGF-I signaling pathways.
  • Analysis of IGF-I's role in muscle physiology.
  • Examination of therapeutic strategies targeting IGF-I.

Main Results:

  • IGF-I's multifaceted role in muscle anabolism is confirmed.
  • Complexity of IGF-I signaling presents challenges and opportunities.
  • Advances in modulating IGF-I offer therapeutic potential.

Conclusions:

  • Targeting IGF-I pathways is a promising strategy for skeletal muscle enhancement.
  • Improving IGF-I bioavailability and potency can drive muscle growth.
  • Further research into IGF-I modulation can lead to novel muscle therapeutics.